SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-005621
Filing Date
2023-01-31
Accepted
2023-01-31 08:29:31
Documents
1
Period of Report
2023-01-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4009
  Complete submission text file 0001209191-23-005621.txt   5489
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Issuer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CONCERT PHARMACEUTICALS, INC. 65 HAYDEN AVENUE, SUITE 3000N LEXINGTON MA 02421
Business Address
Munsie Jeffrey A (Reporting) CIK: 0001703041 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36310 | Film No.: 23570305